Total Tregs, which accounted for 5.0% (median) (range 1.3–10.2%) of CD4+ T cells in healthy controls, were reduced in stroke patients to 2.8% (median) (range 0.03–8.1%) on admission and remained below control values until day 7 (p = 0.0095). This evidence concerns the gene CD4 and stroke disorder.